Ceftazidime Kabi

Medicinal product

(Invented) name

Ceftazidime Kabi

Active substance (s)

Ceftazidimas pentahidratas

Strength

500 mg

Pharmaceutical form

milteliai injekciniam tirpalui

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

J01DD02, Ceftazidime

Marketing authorisation holder

Fresenius Kabi Polska Sp.z.o.o., Lenkija

Date of authorisation

2009-02-03

Date of renewal

2015-09-30

Documents

1448 Pakuotės lapelis 2024 10 08.docx

1448 Ceftazidime Kabi PCS PL 2024 10 08.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

PT/H/0186/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Flakone yra	1 vnt.
Ceftazidimas pentahidratas	500 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
26085	28674	1028674	flakonas	N1		Receptinis	LT/1/09/1448/001	Netiekiama	-	-	No	-	-
33911	36272	1036272	flakonas	N10		Receptinis	LT/1/09/1448/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-11-28	Išregistruotas
2015-09-30	Perregistruotas
2009-02-03	Registruotas